Status:
NOT_YET_RECRUITING
Dachundou No Sugar Added Soymilk for Lipid Modulation
Lead Sponsor:
National Taiwan Sport University
Conditions:
Dyslipidemias
Hypercholesterolemia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Cardiovascular disease is one of the leading causes of death worldwide, and high cholesterol is a major risk factor. Diet is known to play an important role in managing blood lipids. Soy milk is a com...
Detailed Description
Cardiovascular disease remains a leading cause of morbidity and mortality worldwide, with dyslipidemia being one of the most important risk factors. Dietary interventions, such as plant-based proteins...
Eligibility Criteria
Inclusion
- Adults aged 18-65 years
- Fasting total cholesterol (TC) ≥200 mg/dL at both screening (week -2) and baseline (week 0)
- Non-smokers
- No alcohol abuse
- Able and willing to comply with study procedures, dietary restrictions, and follow-up visits
Exclusion
- Pregnant or lactating women
- Menopausal or postmenopausal women
- Diagnosed with chronic diseases under medical treatment (e.g., hypertension, hyperlipidemia, diabetes, liver, kidney, gastrointestinal, cardiovascular disease, cancer)
- Use of dietary supplements or drugs affecting lipid metabolism within 1 month before study entry or during the study
- Cognitive impairment preventing informed consent or protocol compliance
- History of allergy to soy milk, oats, or gluten-containing products
Key Trial Info
Start Date :
September 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT07175766
Start Date
September 15 2025
End Date
August 31 2026
Last Update
September 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan Sport University
Taoyuan District, Taiwan, 333325